SBIRT Glossary


Glossary of terms used on the PGH SBIRT website.
Browse the glossary using this index

Special | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL

Page: (Previous)   1  2  3  4  5  6  (Next)
  ALL

B

Buproprion

A non-nicotine, FDA-approved prescription for smoking cessation. Is sold under the brand names Zyban and Wellbutrin.

C

CAGE

A brief alcoholism screening tool that inquires about a patient's attempts to Cut down on drinking, Annoyance over others' criticism of the patient's drinking, Guilt related to drinking, and use of an alcoholic drink as an Eye opener.

CDC

Centers for Disease Control and Prevention (federal level).

Confidentiality

Extra precautions are taken for the confidentiality of SUD. Information regarding Substance Abuse Problems is confidential and cannot be released to another provider without the specific signed release of information from the patient or a subpoena. This legislation is defined by the Federal Regulation "Confidentiality of Alcohol and Drug Abuse Patient Records.”

CRAFFT

A six-item screening instrument intended specifically for adolescents. It draws upon adult screening instruments, covers alcohol and other drugs, and calls upon situations that are suited to adolescents.

D

DAST

Drug Abuse Screening Test — A brief instrument used to detect drug abuse or dependence disorders. The DAST provides a general measure of lifetime problem severity that can be used to guide further inquiry into drug-related problems and to help determine treatment intensity.

DDAP

Department of Drug and Alcohol Programs (state level: PA).

DDPPQ

Drug and Drug Problems Perception Questionnaire.

Delirium tremens

An alcohol withdrawal syndrome characterized by hallucinations, disorientation, tachycardia, hypertension, low grade fever, agitation and diaphoresis. It occurs in 5% of patients experiencing withdrawal, typically begins between 48 and 72 hours after the last drink, can last one to five days and has a mortality rate of 5% (death is usually due to arrhythmias or complicating illnesses such as pneumonia).

Dependence on a substance

Maladaptive pattern of use leading to clinically significant impairment manifesting three or more of the following within a 12-month period: tolerance, withdrawal, using more than intended, preoccupation with use, narrowing of non-drug use activities, continued use in spite of negative consequences, compulsive use.


Page: (Previous)   1  2  3  4  5  6  (Next)
  ALL